FREDERIC J. HUSER

Fred is a Managing Partner & Principal at the New England Consulting Group and head of our Healthcare practice.

Fred's experience in OTC drugs is extensive, having served as President and CEO of Novartis' North American Consumer Healthcare Division prior to joining New England. While at Novartis and in previous OTC management roles, Fred successfully launched numerous Rx-to-OTC switches including Habitrol (as OTC Private Label), Lamisil AT antifungal, Tavist-D Plus, and Zantac 75. Under Fred's guidance, Novartis' U.S. Consumer Health Company was named "Best OTC Marketer for 1999" by the National Wholesale Druggists Association.

Fred has extensive General Management experience in Rx drugs, having been Vice President and General Manager of the Prescription Medical Division of Burroughs Wellcome Canada, where he initiated the first-ever Canadian pharmaceutical direct-to-consumer advertising for the anti-viral drug Zovirax.

He is one of the leading authorities on the commercial aspects of prescription personalized medicine, having founded Opt-e-scrip, Inc., a Pharmacy Benefit Manager with proprietary technology for determining the cost effectiveness of two chronic care drugs in a single patient.

Fred has expertise in the benefits of outsourcing for the pharmaceutical and biotechnology industries as a former executive responsible for sales and marketing of Cardinal Health's $2+ billion Pharmaceutical Technologies & Services Division. Fred has also been published in the Journal of Managed Care Pharmacy.

Fred holds a BA in history from Duke University and an MBA from the Harvard Graduate School of Business where he concentrated in Finance and International Marketing. Fred has lectured at the Fuqua School of Business at Duke University.